2025-09-10 09:38
IBT presented “Avoiding the severe consequences of NEC” at the NEC Society Symposium in Chicago
Infant Bacterial Therapeutics AB (IBT) presented clinical outcomes following the administration of IBP-9414, an investigational Live Biotherapeutic Product...
Message from CEO IBT continues preparations for the launch of IBP-9414, a drug that can prevent the serious medical consequences of NEC in premature infants...
2025-05-14 07:30
Infant Bacterial Therapeutics (IBT) to present results of “The Connection Study” at ESPGHAN 2025 in Helsinki
Infant Bacterial Therapeutics (IBT) is pleased to announce that results from its pivotal Phase III trial, The Connection Study, will be presented at the...
2025-05-08 17:45
Annual General Meeting of Infant Bacterial Therapeutics
At the Annual General Meeting of Infant Bacterial Therapeutics AB (publ) on May 8, 2025, among other things, the following was resolved: ContactsStaffan...
In accordance with the agreement reached with the FDA on 19 December 2024, IBT has today submitted the Clinical Study Report (CSR) for ‘The Connection...
Message from CEO The US Food and Drug Administration (FDA) has granted IBP-9414 “Breakthrough Therapy Designation.” This means that the FDA...
2025-04-24 07:20
Infant Bacterial Therapeutics (IBT) to Present Results of “The Connection Study” at PAS 2025 in Honolulu
Infant Bacterial Therapeutics (IBT) is pleased to announce that results from its pivotal Phase III trial, “The Connection Study,” will be presented...
2025-04-07 09:40
Notice of Annual General Meeting of Infant Bacterial Therapeutics
Infant Bacterial Therapeutics AB (publ), Reg. No. 556873-8586, with its registered office in Stockholm, gives notice of the Annual General Meeting to be...
The U.S. Food and Drug Administration (FDA) has granted a Breakthrough Therapy designation for IBP-9414’s potential to reduce gastrointestinal-related...
The Annual Report including Corporate Governance Report for 2024 is available on IBT´s website, www.ibtherapeutics.com under the section "Investors...